UnitedHealth Group's second quarter 2026 earnings beat estimates on improved margins, prompting a full-year guidance raise.

UnitedHealth Group reported second quarter 2026 revenues of $112.0 billion and GAAP EPS of $6.04. Despite missing revenue expectations, the company delivered a significant earnings beat driven by improved profitability and raised its full-year 2026 adjusted earnings outlook to a range of $19.50 to $20.00 per share.

Key Highlights

• The company raised its full-year 2026 adjusted EPS guidance to a range of $19.50 to $20.00, citing strong year-to-date performance and an improved outlook.
• The medical care ratio (MCR) was 86.7%, a significant improvement from 89.4% in the prior-year quarter, driven by pricing discipline and medical cost management.
• Earnings from operations increased to $8.0 billion from $5.2 billion year-over-year, reflecting margin expansion across both the UnitedHealthcare and Optum segments.